He X - Search Results

1

Immune checkpoint signaling and cancer immunotherapy.

He X, Xu C. He X, et al. Cell Res. 2020 Aug;30(8):660-669. doi: 10.1038/s41422-020-0343-4. Epub 2020 May 28. Cell Res. 2020. PMID: 32467592 Free PMC article. Review.

2

PD-1: A Driver or Passenger of T Cell Exhaustion?

He X, Xu C. He X, et al. Mol Cell. 2020 Mar 5;77(5):930-931. doi: 10.1016/j.molcel.2020.02.013. Mol Cell. 2020. PMID: 32142689 Free article.

3

Multiple Signaling Roles of CD3ε and Its Application in CAR-T Cell Therapy.

Wu W, Zhou Q, Masubuchi T, Shi X, Li H, Xu X, Huang M, Meng L, He X, Zhu H, Gao S, Zhang N, Jing R, Sun J, Wang H, Hui E, Wong CC, Xu C. Wu W, et al. Among authors: he x. Cell. 2020 Aug 20;182(4):855-871.e23. doi: 10.1016/j.cell.2020.07.018. Epub 2020 Jul 29. Cell. 2020. PMID: 32730808 Free article.

4

Neutralization of Omicron BA.4/BA.5 and BA.2.75 by booster vaccination or BA.2 breakthrough infection sera.

Wang X, Ai J, Li X, Zhao X, Wu J, Zhang H, He X, Zhao C, Qiao R, Li M, Cui Y, Hu Z, Xu C, Zhang W, Wang P. Wang X, et al. Among authors: he x. Cell Discov. 2022 Oct 13;8(1):110. doi: 10.1038/s41421-022-00472-5. Cell Discov. 2022. PMID: 36229428 Free PMC article. No abstract available.

5

Limited enhancement of antibody and B-cell responses to prototype booster vaccination following SARS-CoV-2 Delta breakthrough infection.

Wang X, He X, Jiang S, Fu Z, Jiang S, Zhao X, Zhao C, Li Y, Li D, Zhang W, Ai J, Zhang Y, Xu C, Wang P. Wang X, et al. Among authors: he x. J Med Virol. 2023 Feb;95(2):e28540. doi: 10.1002/jmv.28540. J Med Virol. 2023. PMID: 36722359 No abstract available.

6

Bryostatin-5 blocks stromal cell-derived factor-1 induced chemotaxis via desensitization and down-regulation of cell surface CXCR4 receptors.

He X, Fang L, Wang J, Yi Y, Zhang S, Xie X. He X, et al. Cancer Res. 2008 Nov 1;68(21):8678-86. doi: 10.1158/0008-5472.CAN-08-0294. Cancer Res. 2008. PMID: 18974109

7

Studies on the structure-activity relationship of 1,3,3,4-tetra-substituted pyrrolidine embodied CCR5 receptor antagonists. Part 2: Discovery of highly potent anti-HIV agents.

Li B, Jones ED, Zhou E, Chen L, Baylis DC, Yu S, Wang M, He X, Coates JA, Rhodes DI, Pei G, Deadman JJ, Xie X, Ma D. Li B, et al. Among authors: he x. Bioorg Med Chem Lett. 2010 Sep 1;20(17):5334-6. doi: 10.1016/j.bmcl.2010.05.046. Epub 2010 May 19. Bioorg Med Chem Lett. 2010. PMID: 20674358

8

Studies on the structure-activity relationship of 1,3,3,4-tetra-substituted pyrrolidine embodied CCR5 receptor antagonists. Part 1: Tuning the N-substituents.

Ben L, Jones ED, Zhou E, Li C, Baylis DC, Yu S, Wang M, He X, Coates JA, Rhodes DI, Pei G, Deadman JJ, Xie X, Ma D. Ben L, et al. Among authors: he x. Bioorg Med Chem Lett. 2010 Jul 15;20(14):4012-4. doi: 10.1016/j.bmcl.2010.05.102. Epub 2010 Jun 1. Bioorg Med Chem Lett. 2010. PMID: 20561788

9

Discovery of novel, potent and low-toxicity angiotensin II receptor type 1 (AT1) blockers: Design, synthesis and biological evaluation of 6-substituted aminocarbonyl benzimidazoles with a chiral center.

Han XF, He X, Wang M, Xu D, Hao LP, Liang AH, Zhang J, Zhou ZM. Han XF, et al. Among authors: he x. Eur J Med Chem. 2015 Oct 20;103:473-87. doi: 10.1016/j.ejmech.2015.09.010. Epub 2015 Sep 12. Eur J Med Chem. 2015. PMID: 26397395

10

Magnetoelectric Sensor Operating in d₁₅ Thickness-Shear Mode for High-Frequency Current Detection.

Li F, Wu J, Liu S, Gao J, Lin B, Mo J, Qiao J, Xu Y, Du Y, He X, Zhou Y, Zeng L, Hu Z, Liu M. Li F, et al. Among authors: he x. Sensors (Basel). 2024 Apr 9;24(8):2396. doi: 10.3390/s24082396. Sensors (Basel). 2024. PMID: 38676013

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

26,713 results

Search Page